Hydroxychloroquine: COVID ‘cure’ linked to 17,000 deaths
Hydroxychloroquine: Linked to 17,000 deaths, touted as a COVID 'cure' faced controversy and criticism for its unproven effectiveness and risks.
During the first wave of the COVID-19 pandemic, the rush to find treatments led to the repurposing of existing drugs. One such drug, hydroxychloroquine, briefly promoted by then-US President Donald Trump, has now been linked to an increased mortality rate of up to 11%, according to researchers. The study, published in the open-access journal Biomedicine & Pharmacotherapy, suggests that it may be possible to attribute around 17,000 deaths to hydroxychloroquine. The researchers caution against repurposing drugs in moments of panic, emphasizing the need for better evidence-based approaches during pandemics. Former WHO chief scientist Soumya Swaminathan highlighted the importance of evaluating the risks and effects of drugs, especially when given preventively to a large number of healthy individuals. Swaminathan also stressed the need for efficient processes for putting drugs into rapid human trials during emergencies.